1.
OC-0052: Late toxicity in the randomized phase III Dutch Hypofractionation Trial for prostate cancer patients (HYPRO)
2.
3.
4.
5.
OC-0501: Relating dose outside the prostate with freedom from failure in the Dutch HYPRO trial